Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 8/20 | 0.41 |
| ▸ | PPARA | Q07869 | 7/20 | 0.41 |
| ▸ | PPARD | Q03181 | 4/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 5/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | PSAT1 | Q9Y617 | 1/20 | 0.35 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8608527 | 0.88 | PTGS1 (0.42) | PTGS1PTGS2EGLN1KDM4EPOLB | |
| SCHEMBL8608600 | 0.81 | PPARG (0.39) | PPARGPPARAPPARDEGLN1CPB2 | |
| SCHEMBL8609927 | 0.81 | PTGS1 (0.48) | PTGS1PTGS2EGLN1CPB2KDM4E | |
| SCHEMBL8608923 | 0.78 | RXFP1 (0.39) | PTGS1PTGS2PPARGPPARAPPARD | |
| SCHEMBL8606803 | 0.77 | CPB2 (0.36) | PPARGPPARAPPARDCPB2KDM4E | |
| SCHEMBL9753620 | 0.77 | PTGS1 (0.37) | PTGS1PTGS2EGLN1CPB2KDM4E | |
| SCHEMBL8609437 | 0.74 | PTGS1 (0.46) | PTGS1PTGS2EGLN1KDM4EPOLB | |
| SCHEMBL8609146 | 0.73 | PPARG (0.43) | PPARGPPARAPPARDCPB2FFAR1 | |
| SCHEMBL8607323 | 0.73 | GAA (0.42) | PTGS1PTGS2PPARGPPARAPPARD | |
| SCHEMBL23534275 | 0.73 | PTGS1 (0.48) | PTGS1PTGS2EGLN1KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0436831-A2 | Imidazo[1,2-a]pyridinylalkyl compounds for treatment of neurotoxic injury | G.D. Searle & Co. (US) | 1991-07-17 | — | — | EP | claimed |
| WO-1991008211-A1 | IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF NEUROTOXIC INJURY | G.D. SEARLE & CO. (US) | 1991-06-13 | — | — | WO | claimed |
| US-5716964-A | BRAIN DISORDERS; ANTIISCHEMIC AGENTS | G.D. SEARLE & CO. (US) | 1998-02-10 | — | — | US | disclosed |
| EP-0436831-A2 | Imidazo[1,2-a]pyridinylalkyl compounds for treatment of neurotoxic injury | G.D. Searle & Co. (US) | 1991-07-17 | — | — | EP | disclosed |
| WO-1991008211-A1 | IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF NEUROTOXIC INJURY | G.D. SEARLE & CO. (US) | 1991-06-13 | — | — | WO | disclosed |